Cardiovascular diseases

2023 Activity indicators

2 competitive European projects led: H2020 (RETENTION) & HORIZON EUROPE (STRATIFY-HF)
6 national public projects led: ISCIII, MICINN
8 private projects led
47 clinical trials led
86 publications
IF: 567.62
Q1 publications: 42 (49%)
D1 publications: 15 (17%)
3 thesis
3 awards/recognitions
Members of editorial committees: 5 researchers
1 international patent (EP11845312,5) "Possible use of EMMPRIN inhibitors for the treatment of cardiac damage after ischemia-reperfusion". (Authors: Dr. Carlos Zaragoza et al.) and another in the application phase
7 consensus documents and 1 guide of recommendations

Recognition of Dr. José Luis Zamorano as Highly Cited Researcher or HCR in the field of Clinical Medicine 2023. Clarivate Analytics.
Start of the competitive European project "STRATIFY-HF: Artificial intelligent-based decision support system for risk stratification and early detection of heart failure in primary and secondary care". Requested and granted in the HORIZON-HLTH-2022-STAYHLTH-01-two-stage call and funded by the Horizon Europe Research Framework Programme.
The only public centre in Spain with more than 500 ablations per year in the Arrhythmia Unit, led by Dr. Javier Moreno.
Development of the ApSTEMI study (A double-blind, placebo-controlled, randomized, Phase II clinical study of ApTOLL for the treatment of ST Elevation Myocardial Infarction), with Dr. Zamorano as national coordinator and Dr. Marcelo Sanmartín as PI in our centre.
Transversal line of research of the service led by Dr. Rocío Hinojar. International leaders in percutaneous treatment of tricuspid regurgitation, with 37 Cardiobands implanted in the Hemodynamics Unit, directed by Dr. Ángel Sánchez Recalde.

	Articles	Accum. IF	Mean IF	Articles Q1 or Q2	% in Q1 or Q2	Articles D1	% in D1
2019	73	427.45	5.86	40	55	14	19
2020	87	372.38	4.28	48	55	14	16
2021	95	637.15	6.71	73	77	20	21
2022	102	999.40	9.80	74	73	30	29
2023	83	567.62	6.60	64	74	15	17
	443	3004.00	6.65	299	67	93	21